Full Professor(heuristic)

Chronic Lymphocytic Leukemia Research · Genetics

Compare more Genetics professors.

h-index156
i10-index638
Publications1,743
Citations102,890

Grants

8 total · 0 active

NIH #P01CA236749

Core 2: Biocomputational and Biostatistics Core

Amount
$200K–$300K
Period
2020-07-03 → 2025-06-30
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NIH #P01CA066996

Biostatistics Core

Amount
$100K–$200K
Period
— → 2025-04-30
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P50CA206963

Core 1: Biostatistics

Amount
$100K–$200K
Period
— → 2019-03-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 0 active

NIH #P01CA236749

Core 2: Biocomputational and Biostatistics Core

Amount
$200K–$300K
Period
2020-07-03 → 2025-06-30
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NIH #P01CA066996

Biostatistics Core

Amount
$100K–$200K
Period
— → 2025-04-30
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P50CA206963

Core 1: Biostatistics

Amount
$100K–$200K
Period
— → 2019-03-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NIH #P01CA081534

Biostatistics

Amount
$100K–$200K
Period
2011-12-01 → 2017-08-31
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO

NIH #P50HL110790

A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia

Amount
$2M–$3M
Period
2012-07-15 → 2017-06-30
PIs
4

Awarded at DANA-FARBER CANCER INST

NIH #P01CA109901

Biostatistics and Bioinformatics Core

Amount
<$100K
Period
— → 2016-03-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P01CA092625

Biostatistics and Clinical Trials

Amount
$200K–$300K
Period
— → 2013-06-30
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #P01CA206978

Biostatistics Core

Amount
$100K–$200K
Period
— → —
PIs
1

Awarded at DANA-FARBER CANCER INST

Recent Public Signals

  1. New paper: A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML (Blood Advances)2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-2566-3145

Professor Insights

Career Trajectory